<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5</volume><submitter>Kern F</submitter><pubmed_abstract>Since their discovery in the soil bacterium Sorangium cellulosum, epothilones have emerged as a valuable substance class with promising anti-tumor activity. Because of their benefits in the treatment of cancer and neurodegenerative diseases, epothilones are targets for drug design and pharmaceutical research. The final step of their biosynthesis - a cytochrome P450 mediated epoxidation of epothilone C/D to A/B by CYP167A1 (EpoK) - needs significant improvement, in particular regarding the efficiency of its redox partners. Therefore, we have investigated the ability of various hetero- and homologous redox partners to transfer electrons to EpoK. Hereby, a new hybrid system was established with conversion rates eleven times higher and Vmax of more than seven orders of magnitudes higher as com</pubmed_abstract><journal>Scientific reports</journal><pagination>14881</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4597204</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Highly Efficient CYP167A1 (EpoK) dependent Epothilone B Formation and Production of 7-Ketone Epothilone D as a New Epothilone Derivative.</pubmed_title><pmcid>PMC4597204</pmcid><pubmed_authors>Volmer DA</pubmed_authors><pubmed_authors>Bernhardt R</pubmed_authors><pubmed_authors>Jacquot JP</pubmed_authors><pubmed_authors>Ewen KM</pubmed_authors><pubmed_authors>Kern F</pubmed_authors><pubmed_authors>Dier TK</pubmed_authors><pubmed_authors>Khatri Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Highly Efficient CYP167A1 (EpoK) dependent Epothilone B Formation and Production of 7-Ketone Epothilone D as a New Epothilone Derivative.</name><description>Since their discovery in the soil bacterium Sorangium cellulosum, epothilones have emerged as a valuable substance class with promising anti-tumor activity. Because of their benefits in the treatment of cancer and neurodegenerative diseases, epothilones are targets for drug design and pharmaceutical research. The final step of their biosynthesis - a cytochrome P450 mediated epoxidation of epothilone C/D to A/B by CYP167A1 (EpoK) - needs significant improvement, in particular regarding the efficiency of its redox partners. Therefore, we have investigated the ability of various hetero- and homologous redox partners to transfer electrons to EpoK. Hereby, a new hybrid system was established with conversion rates eleven times higher and Vmax of more than seven orders of magnitudes higher as com</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Oct</publication><modification>2025-04-04T10:50:08.547Z</modification><creation>2019-03-27T01:59:42Z</creation></dates><accession>S-EPMC4597204</accession><cross_references><pubmed>26445909</pubmed><doi>10.1038/srep14881</doi></cross_references></HashMap>